physostigmine has been researched along with Parkinson Disease in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edge, PC; Grell, GA; Melville, GN; Wray, SR | 1 |
| Grimm, RJ | 1 |
| Bergmann, KJ; Clough, CG; Yahr, MD | 1 |
| Casey, DE | 1 |
| Lakke, JP; Lindeboom, SF | 1 |
| Van Woert, MH; Weintraub, MI | 2 |
| Fann, WE; Gerber, CJ; McKenzie, GM | 1 |
| Aquilonius, SM; Sjöström, R | 1 |
| Leopold, N; Sax, DS; Tarsy, D | 1 |
| Duvoisin, RC | 1 |
| Alpert, M; Friedhoff, AJ | 1 |
| Ambani, LM; Bowers, MB; Van Woert, MH | 1 |
| Bhargava, LP; Dandiya, PC | 1 |
| Duvoisin, RC; Katz, R | 1 |
2 review(s) available for physostigmine and Parkinson Disease
| Article | Year |
|---|---|
Current concepts of abnormal motor disorder: an experimental model of attentional deficit disorder.
Topics: Amphetamine; Animals; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Avoidance Learning; Brain; Cholinesterase Inhibitors; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Humans; Huntington Disease; Hyperkinesis; Models, Neurological; Movement Disorders; Nervous System Diseases; Neurotransmitter Agents; Parkinson Disease; Physostigmine; Rats | 1981 |
Deanol in the management of involuntary movement disorders: a review.
Topics: Acetylcholine; Deanol; Dopamine; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Models, Neurological; Movement Disorders; Parkinson Disease; Physostigmine; Research Design; Time Factors | 1977 |
1 trial(s) available for physostigmine and Parkinson Disease
| Article | Year |
|---|---|
Deanol and physostigmine in the treatment of L-dopa-induced dyskinesias.
Topics: Aged; Clinical Trials as Topic; Deanol; Double-Blind Method; Drug Evaluation; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Physostigmine; Placebos | 1978 |
12 other study(ies) available for physostigmine and Parkinson Disease
| Article | Year |
|---|---|
Program disorders of movement.
Topics: Brain Diseases; Central Nervous System Diseases; Cerebellar Ataxia; Diagnosis, Differential; Electromyography; H-Reflex; Humans; Motor Neurons; Movement Disorders; Multiple Sclerosis; Muscle Spasticity; Parkinson Disease; Physostigmine; Reflex, Stretch | 1983 |
Cholinergic and dopaminergic mechanisms in Parkinson's disease after long-term L-DOPA administration.
Topics: Acetylcholine; Adult; Aged; Antiparkinson Agents; Apomorphine; Brain; Dopamine; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease; Physostigmine; Time Factors | 1984 |
Predicting the response to levodopa.
Topics: Calcinosis; Capillaries; Central Nervous System; Cerebrospinal Fluid; Cerebrovascular Disorders; Dihydroxyphenylalanine; Humans; Hypercalcemia; Injections, Intravenous; Male; Middle Aged; Parathyroid Diseases; Parkinson Disease; Phenylacetates; Physostigmine; Probenecid; Prognosis | 1971 |
Physostigmine in rigid Huntington's disease.
Topics: Adult; Female; Genotype; Humans; Huntington Disease; Injections, Intramuscular; Muscle Rigidity; Neurologic Examination; Parkinson Disease; Phenotype; Physostigmine | 1973 |
[Cholinergic and dopaminergic mechanisms in Huntingtons' chorea].
Topics: Acetylcholine; Basal Ganglia; Dopamine; Humans; Huntington Disease; Parkinson Disease; Phenylacetates; Physostigmine; Synaptic Transmission | 1971 |
Physostigmine in choreiform movement disorders.
Topics: Acetylcholine; Adult; Aged; Art; Athetosis; Chorea; Corpus Striatum; Dihydroxyphenylalanine; Female; Handwriting; Humans; Huntington Disease; Injections, Intravenous; Male; Middle Aged; Motor Activity; Motor Skills; Parkinson Disease; Phenothiazines; Physostigmine; Posture; Synaptic Transmission | 1974 |
Cholinergic-anticholinergic antagonism in parkinsonism.
Topics: Adult; Basal Ganglia; Curare; Drug Antagonism; Electric Stimulation; Female; Handwriting; Humans; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Parkinson Disease, Postencephalitic; Physostigmine; Quaternary Ammonium Compounds; Scopolamine | 1967 |
A dopaminergic-cholinergic mechanism in production of psychotic symptoms.
Topics: Amphetamine; Animals; Brain; Brain Chemistry; Dopamine; Humans; Models, Biological; Parasympatholytics; Parkinson Disease; Physostigmine; Psychopharmacology; Psychotic Disorders; Rats; Receptors, Adrenergic; Receptors, Cholinergic; Receptors, Drug; Tranquilizing Agents | 1973 |
Physostigmine effects on phenothiazine-induced extrapyramidal reactions.
Topics: Adult; Antiparkinson Agents; Chlorpromazine; Drug Hypersensitivity; Extrapyramidal Tracts; Female; Handwriting; Humans; Male; Mental Disorders; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Physostigmine; Salicylates; Schizophrenia; Substance-Related Disorders; Time Factors; Trifluoperazine; Tropanes | 1973 |
Reversal by levodopa of cholinergic hypersensitivity in Parkinson's disease.
Topics: Brain; Dihydroxyphenylalanine; Dopamine; Drug Hypersensitivity; Female; Handwriting; Humans; Injections, Intravenous; Male; Middle Aged; Movement Disorders; Neurologic Manifestations; Neurons; Parasympatholytics; Parasympathomimetics; Parkinson Disease; Physostigmine; Stimulation, Chemical; Trihexyphenidyl; Tropanes | 1971 |
The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
Topics: Animals; Dextroamphetamine; Diphenhydramine; Imipramine; Iproniazid; Isocarboxazid; Mice; Monoamine Oxidase Inhibitors; Nialamide; Nicotine; Nortropanes; Pargyline; Parkinson Disease; Parkinson Disease, Secondary; Perphenazine; Phenelzine; Physostigmine; Rats; Scopolamine; Sulfonic Acids; Tolazoline; Tremor; Tremorine; Trihexyphenidyl; Tryptamines | 1968 |
Reversal of central anticholinergic syndrome in man by physostigmine.
Topics: Aged; Ataxia; Central Nervous System Diseases; Child; Cognition Disorders; Delirium; Female; Hallucinations; Humans; Male; Middle Aged; Neostigmine; Parasympatholytics; Parkinson Disease; Physostigmine; Preanesthetic Medication; Scopolamine; Speech Disorders; Trihexyphenidyl | 1968 |